Interleukin-6 and its receptor; from cloning to clinic

International Archives of Allergy and Immunology

Volumn 99, Issue 2-4, 1992, Pages 172-177

  Kishimoto, Tadamitsu ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

B cell differentiation; CNTF; Gp 130; IL 6; IL 6 receptor; LIF; Myeloma plasmacytoma; NF IL 6; OM

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; INTERLEUKIN 11; INTERLEUKIN 6; INTERLEUKIN RECEPTOR; LEUKEMIA INHIBITORY FACTOR; ONCOSTATIN M;

ANTIBODY PRODUCTION; B LYMPHOCYTE; BINDING SITE; CARCINOMA CELL; CELL DIFFERENTIATION; CELL GROWTH; CELL MATURATION; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; GENE INDUCTION; GROWTH INHIBITION; KERATINOCYTE; LEUKEMIA CELL; LIVER CELL; LYMPHOCYTE DIFFERENTIATION; MEGAKARYOCYTE; MESANGIUM CELL; MYELOMA CELL; PHEOCHROMOCYTOMA CELL; PLASMACYTOMA; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION;

EID: 0027057610     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000236243     Document Type: Article

References (39)

1. Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Malsuda T, Kashiwamura S, Nakajima K, Koyama K, Iwamatsu A, Tsunasawa S, Sakiyama F, Matsui H, Takara Y, Taniguchi T, Kishimolo T: Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 1986; 324: 73-76.
2. Zilberstein A, Ruggieri R, Korn JH, Revel M: Structure and expression of cDNA and genes for human interferon-beta-2. a distinct species inducibiy by growth-stimulatorv cytokines. EMBO J 1986; 5: 2529-2537.
3. Haegeman G, Content J, Volckaert G, Derynck R, Tavernier J, Fiers W: Structural analysis of the sequence encoding for an inducible 26-kDa protein in human fibroblasts. Eur J Biochem 1986; 159: 625-632.
4. Van Damme J, Opdenakker G, Simpson RJ, Rubira MR, Cayphas S, Vink A, Billian A, Snick JV: Identification of the human 26-kDa protein, interferon β2 (INFβ2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor. J Exp Med 1987; 165: 914-919.
5. Kishimoto T: The biology of interleukin-6. Blood 1989; 74: 1-10.
6. Takatsuki F, Okano A, Suzuki C, Chieda R, Takahara Y, Hirano T, Kishimoto T, Hamuro J Akiyama Y: Human recombinant interleukin-6/B cell stimulatory factor 2 IL-6 (BSF-2) augments murine antigen-specific antibody responses in vitro and in vivo. J Immunol 1988; 141: 3072-3077.
7. Muraguchi A, Hirano T, Tang B, Matsuda T, Horii Y, Nakajima K, Kishimoto T: The essential role of B cell stimulatory factor 2 BSF-2/ IL-6 for the terminal differentiation of B cells. J Exp Med 1988; 167: 332-344.
8. Andus T, Geiger T, Hirano T, Northoff H, Ganter U, Baucer J, Kishimoto T, Heinrich PC: Recombinant human B cell stimulatory factor 2 (BSF2/IFN-β2) regulates β-fibrinogen and albumin mRNA levels in fao-9 cells. FEBS Lett 1987; 22: 18-22.
9. Gauldie J, Richards C, Harnish D, Lansdorp P, Baumann H: Interferon β2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 1987; 84: 7251-7256.
10. Geiger T, Andus T, Klapproth J, Hirano T, Kishimoto T, Heinrich PC: Induction of rat acute-phase proteins by interleukin-6 in vivo. Eur J Immunol 1988; 18: 717-721.
11. Akira S, Isshiki H, Nakajima T, Kinoshita S, Nishio Y, Natsuka S, Kishimoto T: Regulation of expression of the IL-6 gene. Structure and function of the transcription factor NF-IL6. Ciba Found Symp 167, Wiley. Chichester, 1992, pp 47-67.
12. Ikebuchi K, Wong GG, Clark SC, Ihle JN, Hirai Y, Ogawa M: Interleukin-6 enhancement of interleukin-3-dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci USA 1987; 84: 9035-9039.
13. Suematsu S, Matsuda T, Aozasa K, Akira S, Nakano N, Ohno S, Miyazaki J, Yamamura K, Hirano T, Kishimoto T: IgG, plasmacytosis in interleukin 6 transgenic mice. Proc Natl Acad Sci USA 1989; 86: 7547-7551.
14. Ishibashi T, Kimura H, Shikama Y, Uchida T, Kariyone S, Hirano T, Kishimoto T, Takatsuki F, Akiyama Y: Interleukin-6 is a potent thrombopoietic factor in vivo in mice. Blood 1989; 74: 1241-1244.
15. Ishibashi T, Kimura H, Uchida T, Kariyone S, Friese P, Burstein SA: Human interleukin-6 is a direct promoter of maturation of megakaryocytes in vitro. Proc Natl Acad Sci USA 1989; 86: 5953-5957.
16. Shabo Y Lotem J, Rubinbstein M, Revel M, Clark SC, Wolf SF, Kamen R, Sachs L: The myeloid blood cell differentiation-inducing protein MGI-2A is interleukin-6. Blood 1988; 72: 2070-2073.
17. Miyaura C, Onozaki K, Akiyama Y, Taniyama T, Hirano T, Kishimoto T, Suda T: Recombinant human interleukin 6 (B-cell stimulatory factor 2) is a potent inducer of differentiation of mouse myeloid leukemia cells (M1). FEBS Lett 1988; 234: 17-21.
18. Gearing D, Gough NM, King JA, Hilton DJ, Nicola NA, Simpson RJ, Nice EC, Kelso A, Metcalf D: Molecular cloning and expression of cDNA encoding a murine myeloid leukemia inhibitory factor (LIF). EMBOJ 1987; 6: 3995-4002.
19. Hirano T, Suematsu S, Matsusaka T, Matsuda T, Kishimoto T: The role of interleukin 6 in plasmacytogenesis: in: Polyfunctional Cytokines: IL-6 and LIF. Ciba Found Symp 167. Wiley, Chichester, 1992, pp 188-200.
20. Satoh T, Nakamura S, taga T, Matsuda T, Hirano T, Kishimoto T, kaziro Y: Induction of neuronal differentiation in PC12 cells by B-cell stimulatory factor 2/interleukin-6. Mol Cell Biol 1988; 8: 3546-3549.
21. Grossmann RM, Krueger J, Yourish D, Granelli-Piperno A, Murphy DP, May LT, Kupper TS, Sehgal PB, Gottlieb AB: Interleukin-6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 1989; 86: 6367-6371.
22. Yoshizaki K, Nishimoto N, Matsumoto K, Tagoh H, Taga T, Deguchi Y, Kuritani T, Hirano T, Hashimoto K, Okada N, Kishimoto T: Interleukin-6 and expression of its receptor on epidermal keratinocytes. Cytokine 1990; 2: 381-387.
23. Lotz M, Kirik F, Kabouridis R, Tsoukas C, Hirano T, Kishimoto T, Carson DA: B cell stimulating factor 2/interleukin-6 is a costimulant for human thymocytes and T lymphocytes. J Exp Med 1988; 167: 1253-1258.
24. Houssiau FA, Coulie PG, Olive D, Van Snick J: Synergistic activation of human T cells by interleukin-1 and interleukin-6. Eur J Immunol 1988; 18: 653-656.
25. Takai Y, Wong GG, Clark SC, Burakoff SJ, Herrmann SH: B cell stimulatory factor 2 is involved in the differentiation of cytotoxic T lymphocytes. J Immunol 1988; 140: 508-512.
26. Taga T Kishimoto T: IL-6 receptor: in Cochrane CG, Gimbrone MA Jr. (eds): Cellular and Molecular Mechanisms of Inflammation. Receptors of Inflammatory Cells: Structure-function Relationships. San Diego. Academic Press, 1990, pp 219-243.
27. Taga T, Kawanishi Y, Hardy RR, Hirano T, Kishimoto T: Receptors for B cell stimulatory facor 2 (BSF 2): Quantitation, specificity, distribution and regulation of the expression. J Exp Med 1987; 166: 967-981.
28. Hirata Y, Taga T, Hibi M, Nakano N, Hirano T, Kishimoto T: Characterization of IL-6 receptor expression by monoclonal and polyclonal antibodies. J Immunol 1989; 143: 2900-2906.
29. Yamasaki K, Taga T, Hirata H, Yawata H, Kawanishi Y Seed B, Taniguchi T, Hirano T, Kishimoto T: Cloning and expression of human interleukin 6 (BSF-2/IFNβ) receptor. Science 1988; 241: 825-828.
30. Bazan JF: Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 1990; 87: 6934-6938.
31. Taga T, Hibi M, Hirata Y, Yamasaki K, Yasukawa K, Matsuda T, Hirano T, Kishimoto T: Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 1989; 58: 573-581.
32. Hibi M, Murakami M, Saito M, Hirano T, Taga T, Kishimoto T: Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 1990; 63: 1149-1157.
33. Gearing D, Thut CJ, VandenBos T, Gimpel SD, Delaney PB, King J, Price V, Cosman D, Beckman MP: Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer. gp130. EMBO J 1991; 10: 2839-2348.
34. Gearing D, Comeau MR, Friend DJ, Gimpel SD, Thut CJ, McGoutry J Brasher KK, King JA, Gillis S, Mosley B, Ziegler SF, Cosman D: The IL-6 Signal transduer, gp130: An ocostatin M receptor and affinity converter for the LIF receptor. Science 1992; 253: 1434-1437.
35. Ip NY, Nye SH, Boulton TG, Dasvis S, Taga T, Li Y, Birren SJ, Yasukawa K, Kishimoto T, Anderson DJ, Stahl N, Yancopoulos GD: CNTF and LIF act on neuronal cells via shared signaling pathways that involved the IL-6 signal transducing receptor component gp130. Cell 1992; 69: 1121-1132.
36. Davis S, Aldrich TH, Valenzuela DM, Wong V, Furth ME, Squinto SP, Yancopoulos GD: Science 1991; 253: 59-63.
37. Taga T, Narazaki M, Yasukawa K, Saito T, Miki D, Hamaguchi M, Davis S, Shoybo M, Yancopoulos GD, Kishimoto T: Functional inhibition of hematopoietic- and neutrophic-cytokines (LIF. OM. and CNTF) by blocking IL-6 signal transducer. gp130. Proc Natl Acad Sci USA 1992, in press.
38. Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H, Kuramoto A, Kishimoto T: Autocrine generation and requirement of BSF-2/ IL-6 for human multiple myelomas. Nature 1988; 332: 83-85.
39. Klein B, Wildense J, Zhang XG, Jourdan M, Boiron JM, Brochier J, Liautard J, Merlin M, Clement C, Morel-Fournier B, Lu ZY, Mannoni P, Sany J, Bataille R: Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood 1992; 78: 1198-1204.